Recovery of endocrine function after islet and pancreas transplantation (Q26822596)

language of work or name

1 reference

October 2012

1 reference

published in

Current diabetes report

1 reference

volume

12

1 reference

issue

5

1 reference

page(s)

587-96

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-012-0294-3

exact match

0 references

cites work

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Improvement in outcomes of clinical islet transplantation: 1999-2010.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Long-term outcome after pancreas transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

State of the art of clinical islet transplantation and novel protocols of immunosuppression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Islet versus pancreas transplantation in type 1 diabetes: competitive or complementary?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Insulin reciprocally regulates glucagon secretion in humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Islet transplantation for brittle type 1 diabetes: the UIC protocol

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

The rise and fall of insulin secretion in type 1 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Hypoglycemia in diabetes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Further evidence for amyloid deposition in clinical pancreatic islet grafts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Intraportally transplanted pancreatic islets revascularized from hepatic arterial system

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Göttingen minipigs in vivo.

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Consequences on beta-cell function and reserve after long-term pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Simple measures to monitor beta-cell mass and assess islet graft dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

C-peptide and glucose values in the peritransplant period after intraportal islet infusions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

{beta}-Cell function following human islet transplantation for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Positron emission tomography in clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Hepatocyte Growth Factor Gene Therapy for Pancreatic Islets in Diabetes: Reducing the Minimal Islet Transplant Mass Required in a Glucocorticoid-Free Rat Model of Allogeneic Portal Vein Islet Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Cross-sectional and prospective association between proinsulin secretion and graft function after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Impaired proinsulin processing is a characteristic of transplanted islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Amyloid and transplanted islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432697

Intraportal transplantation of pancreatic islets into livers of diabetic rats. Reinnervation of islets and regulation of insulin secretion by the hepatic sympathetic nerves

28 November 2018

1 reference

12 December 2020

Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM

1 reference

12 December 2020

Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation

1 reference

12 December 2020

Effects of beta cell granule components on human islet amyloid polypeptide fibril formation

1 reference

12 December 2020

Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy

1 reference

12 December 2020

Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects

1 reference

12 December 2020

Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes

1 reference

12 December 2020

Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes

1 reference

12 December 2020

Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients

1 reference

12 December 2020

The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects

1 reference

12 December 2020

Widespread amyloid deposition in transplanted human pancreatic islets

1 reference

12 December 2020

Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass

1 reference

12 December 2020

Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus

1 reference

12 December 2020

Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients

1 reference

12 December 2020

Prolonged exposure of human beta-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine

1 reference

12 December 2020

One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up

1 reference

12 December 2020

Proinsulin processing and transplanted islets

1 reference

12 December 2020

Risk factors and impact of delayed graft function after pancreas transplants

1 reference

12 December 2020

Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy

1 reference

12 December 2020

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

1 reference

12 December 2020

Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control

1 reference

12 December 2020

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells

1 reference

12 December 2020

Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site

1 reference

12 December 2020

Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium

1 reference

12 December 2020

Effect of pancreas transplantation on glucose counterregulation in insulin-dependent diabetic patients prone to severe hypoglycaemia

1 reference

12 December 2020

Lack of feedback inhibition of insulin secretion in denervated human pancreas

1 reference

12 December 2020

Evidence that suppression of insulin secretion by insulin itself is neurally mediated

1 reference

12 December 2020

Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM

1 reference

12 December 2020

Abstracts of the American Transplant Congress 2008. May 30-June 4, 2008. Toronto, Ontario, Canada

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0294-3

7 January 2021